Generation and validation of a mouse model of the phospholamban p.Arg14del mutation

被引：0
|
作者：
Eijgenraam, T. R. [1 ]
Sillje, H. H. W. [1 ]
De Boer, R. A. [1 ]
机构：
[1] Univ Med Ctr Groningen, Expt Cardiol, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
854
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model
    Van der Heide, M.
    Verstraelen, T. E.
    Van Lint, F. H. M.
    Bosman, L. P.
    De Brouwer, R.
    Proost, V. M.
    Abeln, G. S.
    Schoonderwoerd, B. A.
    Houweling, A. C.
    Gimeno-Blanes, J. R.
    Asselbergs, F. W.
    De Boer, R. A.
    Van den Berg, M. P.
    Van Tintelen, J. P.
    Wilde, A. A. M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 673 - 673
  • [2] A mutation specific prediction model for ventricular arrhythmias in the phospholamban (PLN) p.Arg14del cardiomyopathy
    Verstraelen, T. E.
    Van Lint, F. H. M.
    Bosman, L. P.
    Abeln, B. G. S.
    Asselbergs, F. W.
    Van Der Zwaag, P. A.
    Van Den Berg, M. P.
    Van Tintelen, J. P.
    Wilde, A. A. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3083 - 3083
  • [3] The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
    van der Heijden, J. F.
    Hassink, R. J.
    NETHERLANDS HEART JOURNAL, 2013, 21 (06) : 284 - 285
  • [4] The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
    J. F. van der Heijden
    R. J. Hassink
    Netherlands Heart Journal, 2013, 21 : 284 - 285
  • [5] Echocardiography Reveals Biventricular Abnormalities in Presymptomatic Phospholamban p.Arg14del Mutation Carriers
    te Rijdt, Wouter P.
    Hummel, Yoran M.
    van Tintelen, J. Peter
    de Boer, Rudolf A.
    van den Berg, Maarten P.
    CIRCULATION, 2014, 130
  • [6] Phospholamban p.Arg14del Cardiomyopathy: A Japanese Case Series
    Tabata, Tomoka
    Kuramoto, Yuki
    Ohtani, Tomohito
    Miyawaki, Hiroshi
    Miyashita, Yohei
    Sera, Fusako
    Kioka, Hidetaka
    Higo, Shuichiro
    Asano, Yoshihiro
    Hikoso, Shungo
    Sakata, Yasushi
    INTERNAL MEDICINE, 2022, 61 (13) : 1987 - 1993
  • [7] Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
    P. A. van der Zwaag
    I. A. W. van Rijsingen
    R. de Ruiter
    E. A. Nannenberg
    J. A. Groeneweg
    J. G. Post
    R. N. W. Hauer
    I. C. van Gelder
    M. P. van den Berg
    P. van der Harst
    A. A. M. Wilde
    J. P. van Tintelen
    Netherlands Heart Journal, 2013, 21 : 286 - 293
  • [8] Phospholamban p.arg14del Mutation in a Spanish Family With Arrhythmogenic Cardiomyopathy: Evidence for a European Founder Mutation
    Maria Lopez-Ayala, Jose
    Boven, Ludolf
    van den Wijngaard, Arthur
    Penafiel-Verdu, Pablo
    van Tintelen, Johan Peter
    Ramon Gimeno, Juan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (04): : 346 - 349
  • [9] Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates which are degraded by autophagy
    te Rijdt, W. P.
    Tintelen, J. P.
    Vink, A.
    van der Wal, A. C.
    de Boer, R. A.
    van den Berg, M. P.
    Suurmeijer, A. J. H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 17 - 17
  • [10] A novel phospholamban p.Arg14del cardiomyopathy mouse line treated with heart failure medication
    Eijgenraam, T. R.
    Schouten, E. M.
    Gehlken, A. C. D. I.
    Dokter, M. M.
    Sillje, H. H. W.
    De Boer, R. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 477 - 477
12345